In particular, an evidence-based approach to prognostic markers is required, as it is usually difficult to ascertain the benefit of a marker from single studies and a clear view is only likely to ...

In an effort to provide some transparency to this situation, an international panel of researchers has called for initiation of a comprehensive marker study registry in oncology, and a prototype ...

Laura Graff's story on the Jill Marker case in Sunday's Journal brought the focus back where it belongs — on Marker. She courageously carries on in the wake of a ...

Prognostic markers help to stratify patients for treatment by identifying patients with different risks of outcome (e.g. recurrence of disease), and are important tools in the management of cancer ...